Ophthalmology · Port Jefferson, NY
NPI
1114176278
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
125 Oakland Ave, Suite 101
Port Jefferson, NY, 11777
Phone (631) 828-7100
Groups this clinician bills Medicare through
Medicare paid, 2024
$619K
8,356 services
Medicare patients, 2024
2,004
Average age 76
Drug cost, 2024
$1.9M
5,814 prescriptions
Company payments, 2025
$1,648
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anzhelika Vaccaro was code 92020 (ophthalmological e&m), 1,624 times for 1,471 patients. In total Anzhelika Vaccaro billed 8,356 services in 43 codes, and Medicare paid $619K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92020 Ophthalmological E&M | Office | 1,624 | 1,471 | $23.61 | $38K |
| 92014 Ophthalmological E&M | Office | 1,538 | 1,494 | $104.10 | $160K |
| 99213 Office E&M - Established | Office | 1,507 | 1,087 | $75.36 | $114K |
| 92133 Computerized Ophthalmic Imaging | Office | 642 | 607 | $31.14 | $20K |
| 92083 Vision, Hearing, and Speech Services | Office | 554 | 512 | $55.25 | $31K |
| 92250 Angiography | Office | 538 | 514 | $31.59 | $17K |
| 92134 Computerized Ophthalmic Imaging | Office | 476 | 393 | $35.32 | $17K |
| 83861 Clinical Chemistry | Office | 317 | 135 | $22.03 | $6,984 |
| 99214 Office E&M - Established | Office | 308 | 273 | $111.56 | $34K |
| 92136 Ultrasound - Nonspecific | Office | 162 | 131 | $39.03 | $6,324 |
| 66984 Cataract Surgery | Facility | 134 | 100 | $461.49 | $62K |
| 76514 Ultrasound - Nonspecific | Office | 96 | 96 | $9.27 | $890 |
| 92004 Ophthalmological E&M | Office | 87 | 87 | $122.04 | $11K |
| 92082 Vision, Hearing, and Speech Services | Office | 86 | 84 | $41.66 | $3,583 |
| 66821 Cataract Surgery | Office | 61 | 48 | $313.47 | $19K |
By year: 2022 $605K for 7,934 services; 2023 $633K for 8,215 services; 2024 $619K for 8,356 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 317 | 135 | $22.03 | $6,984 |
Medicare prescription drug claims, 2024
In 2024, the drug Anzhelika Vaccaro prescribed most often to Medicare patients was Latanoprost, with 967 prescriptions and refills. In total Anzhelika Vaccaro wrote 5,814 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 967 | 2,303 | 308 | $11K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 548 | 1,055 | 144 | $9,607 |
| Brimonidine Tartrate Generic | 457 | 1,049 | 149 | $14K |
| Lumigan Bimatoprost | 437 | 1,003 | 136 | $282K |
| Dorzolamide Hcl Generic | 344 | 674 | 93 | $6,149 |
| Timolol Maleate Generic | 299 | 707 | 93 | $4,207 |
| Prednisolone Acetate Generic | 252 | 302 | 149 | $8,335 |
| Loteprednol Etabonate Generic | 179 | 239 | 91 | $30K |
| Pilocarpine Hcl Generic | 165 | 405 | 56 | $11K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 155 | 383 | 52 | $35K |
| Alphagan P Brimonidine Tartrate | 153 | 369 | 51 | $73K |
| Combigan Brimonidine Tartrate/Timolol | 153 | 320 | 47 | $74K |
| Ofloxacin Generic | 111 | 111 | 77 | $1,127 |
| Tafluprost Tafluprost/Pf | 104 | 226 | 32 | $26K |
| Rhopressa Netarsudil Mesylate | 98 | 214 | 39 | $73K |
Brand drugs: 2,407 claims; generic drugs: 3,407 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anzhelika Vaccaro $1,648 ($1,648 in general payments such as food, travel and fees) from 10 companies. The largest payer was Alcon Vision LLC with $615.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 18 | $615 |
| Abbvie Inc. ABBV | 14 | $339 |
| Glaukos Corporation GKOS | 2 | $296 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $128 |
| Harrow Eye, LLC | 3 | $72.54 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $68.86 |
| Oyster Point Pharma, Inc. | 2 | $52.72 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $37.59 |
| Thea Pharma Inc. | 1 | $24.84 |
| RxSight Inc RXST | 1 | $14.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.